Press releases - Ypsomed - Group
Oct 23, 2024 · Burgdorf – Ypsomed (SIX: YPSN) continues its growth trend and achieved consolidated sales of CHF 255.4 million in the first six months of the 2023/24 financial year …
Ypsomed significantly increases its operating profit and plans to ...
May 22, 2024 · Burgdorf – Ypsomed (SIX: YPSN) continues its growth trend and achieved consolidated sales of CHF 548.5 million in the financial year 2023/24 (previous year: CHF …
Selfcare Solutions - Ypsomed - Group
Ypsomed Delivery Systems (YDS) provides a complete range of technologies and services for reliable and user-friendly injection systems for self-medication. Our customers are …
Media & Investors - Ypsomed - Group
Oct 23, 2024 · Ypsomed significantly increases sales and decides to initiate the sale of Diabetes Care
Ypsomed enhances self-injection device platforms with integrated …
Oct 5, 2023 · By enhancing its device platform offering with integrated end-to-end HF services, Ypsomed is championing a comprehensive service approach to combination product …
Ypsomed significantly increases sales and decides to initiate the …
Nov 13, 2024 · The Ypsomed Diabetes Care (YDC) business area generated sales of CHF 98.1 million in the first half of 2024/25 (previous year: CHF 72.6 million). Adjusted for the sale of the …
Ypsomed concludes a long-term supply agreement for large …
Burgdorf – Ypsomed (SIX: YPSN) has concluded a long-term supply agreement with Novo Nordisk for large quantities of autoinjectors. The autoinjectors will be used to administer drugs …
News - Ypsomed Delivery Systems
Oct 23, 2024 · 12/06/2024 - 7:00am News – Ypsomed Delivery Systems Burgdorf – medac GmbH has selected an autoinjector from Ypsomed for the relaunch of its methotrexate pen. The …
Company - Ypsomed - Group
Nov 13, 2024 · Ypsomed is the leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist. The company has celebrated …
Go-ahead for a new Ypsomed production facility in China
In order to be able to efficiently serve the rapidly growing Chinese market for injection systems, Ypsomed is investing over CHF 35 million in the new manufacturing plant in a first phase. …